Evidence map

TrialEBioMedicine2016

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.

David K Packham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

99 papers cite itlatest 60 shown

2016
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27743903